| NDC Code | 62856-535-30 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62856-535-30) |
|---|
| Product NDC | 62856-535 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Belviq Xr |
|---|
| Non-Proprietary Name | Lorcaserin Hydrochloride Hemihydrate |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20160715 |
|---|
| End Marketing Date | 20220531 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA208524 |
|---|
| Manufacturer | Eisai Inc. |
|---|
| Substance Name | LORCASERIN HYDROCHLORIDE HEMIHYDRATE |
|---|
| Strength | 20 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cytochrome P450 2D6 Inhibitors [MoA], Serotonin 2c Receptor Agonists [MoA], Serotonin-2c Receptor Agonist [EPC] |
|---|
| DEA Schedule | CIV |
|---|